Astria Therapeutics
ATXS
ATXS
35 hedge funds and large institutions have $63.8M invested in Astria Therapeutics in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
40% less funds holding
Funds holding: 58 → 35 (-23)
82% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 28
Holders
35
Holding in Top 10
–
Calls
$262K
Puts
$354K
Top Buyers
| 1 | +$6M | |
| 2 | +$3.7M | |
| 3 | +$2.39M | |
| 4 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
+$2.03M |
| 5 |
Renaissance Technologies
New York
|
+$411K |
Top Sellers
| 1 | -$6.73M | |
| 2 | -$3.75M | |
| 3 | -$2.48M | |
| 4 |
Millennium Management
New York
|
-$974K |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$343K |